Contact
Please use this form to send email to PR contact of this press release:
Ovid Therapeutics Announces Proposed Concurrent Public Offerings of Common Stock and Preferred Stock
TO:
Please use this form to send email to PR contact of this press release:
Ovid Therapeutics Announces Proposed Concurrent Public Offerings of Common Stock and Preferred Stock
TO: